Brodeur GM - Search Results

1

Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.

Katzenstein HM, Bowman LC, Brodeur GM, Thorner PS, Joshi VV, Smith EI, Look AT, Rowe ST, Nash MB, Holbrook T, Alvarado C, Rao PV, Castleberry RP, Cohn SL. Katzenstein HM, et al. Among authors: brodeur gm. J Clin Oncol. 1998 Jun;16(6):2007-17. doi: 10.1200/JCO.1998.16.6.2007. J Clin Oncol. 1998. PMID: 9626197

2

Molecular basis of clinical heterogeneity in neuroblastoma.

Brodeur GM, Nakagawara A. Brodeur GM, et al. Am J Pediatr Hematol Oncol. 1992 May;14(2):111-6. doi: 10.1097/00043426-199205000-00004. Am J Pediatr Hematol Oncol. 1992. PMID: 1356315 Review.

3

Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study.

Shuster JJ, McWilliams NB, Castleberry R, Nitschke R, Smith EI, Altshuler G, Kun L, Brodeur G, Joshi V, Vietti T, et al. Shuster JJ, et al. Am J Clin Oncol. 1992 Aug;15(4):295-303. doi: 10.1097/00000421-199208000-00004. Am J Clin Oncol. 1992. PMID: 1514525

4

Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.

Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM. Fong CT, et al. Among authors: brodeur gm. Cancer Res. 1992 Apr 1;52(7):1780-5. Cancer Res. 1992. PMID: 1551108

5

Neuroblastoma, retinoblastoma, and brain tumors in children.

Brodeur GM, Saylors RL 3rd. Brodeur GM, et al. Curr Opin Oncol. 1991 Jun;3(3):485-96. doi: 10.1097/00001622-199106000-00007. Curr Opin Oncol. 1991. PMID: 1892917 Review.

6

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. Look AT, et al. Among authors: brodeur gm. J Clin Oncol. 1991 Apr;9(4):581-91. doi: 10.1200/JCO.1991.9.4.581. J Clin Oncol. 1991. PMID: 2066755 Clinical Trial.

7

Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.

Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM. Cohn SL, et al. Among authors: brodeur gm. Oncogene. 1990 Dec;5(12):1821-7. Oncogene. 1990. PMID: 2284101

8

Oncogene amplification in pediatric brain tumors.

Wasson JC, Saylors RL 3rd, Zeltzer P, Friedman HS, Bigner SH, Burger PC, Bigner DD, Look AT, Douglass EC, Brodeur GM. Wasson JC, et al. Among authors: brodeur gm. Cancer Res. 1990 May 15;50(10):2987-90. Cancer Res. 1990. PMID: 2334901

9

A surgical perspective on the current staging in neuroblastoma--the International Neuroblastoma Staging System proposal.

Smith EI, Haase GM, Seeger RC, Brodeur GM. Smith EI, et al. Among authors: brodeur gm. J Pediatr Surg. 1989 Apr;24(4):386-90. doi: 10.1016/s0022-3468(89)80277-5. J Pediatr Surg. 1989. PMID: 2732883

10

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, et al. Brodeur GM, et al. J Clin Oncol. 1988 Dec;6(12):1874-81. doi: 10.1200/JCO.1988.6.12.1874. J Clin Oncol. 1988. PMID: 3199170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters